Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ)
CNY 2.75
(-0.36%)
CNY 2.75
(-0.36%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -381.73 Million CNY | -5.64% |
| 2022 | -361.34 Million CNY | 29.08% |
| 2021 | -509.52 Million CNY | -21.37% |
| 2020 | -419.82 Million CNY | 68.19% |
| 2019 | -1.31 Billion CNY | 8.01% |
| 2018 | -1.43 Billion CNY | -1.64% |
| 2017 | -1.41 Billion CNY | -43.14% |
| 2016 | -986.31 Million CNY | 45.97% |
| 2015 | -1.82 Billion CNY | -20369.9% |
| 2014 | 9 Million CNY | 101.79% |
| 2013 | -501.97 Million CNY | 13.83% |
| 2012 | -582.57 Million CNY | 24.28% |
| 2011 | -769.34 Million CNY | -2682.41% |
| 2010 | 29.79 Million CNY | 642.56% |
| 2009 | 4.01 Million CNY | -57.26% |
| 2008 | 9.38 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -181.22 Million CNY | 52.53% |
| 2024 Q3 | -268.97 Million CNY | 11.27% |
| 2024 Q2 | -296.42 Million CNY | -63.57% |
| 2023 Q2 | -392.05 Million CNY | -16.95% |
| 2023 Q3 | -349.41 Million CNY | 10.88% |
| 2023 FY | -381.73 Million CNY | -5.64% |
| 2023 Q1 | -335.24 Million CNY | 7.22% |
| 2023 Q4 | -381.73 Million CNY | -9.25% |
| 2022 Q2 | -513.74 Million CNY | -95.55% |
| 2022 FY | -361.34 Million CNY | 29.08% |
| 2022 Q4 | -361.34 Million CNY | -534.55% |
| 2022 Q3 | -56.94 Million CNY | 88.92% |
| 2022 Q1 | -262.72 Million CNY | 48.44% |
| 2021 Q1 | -373.1 Million CNY | 11.13% |
| 2021 Q3 | -158.07 Million CNY | 17.48% |
| 2021 Q4 | -509.52 Million CNY | -222.34% |
| 2021 Q2 | -191.56 Million CNY | 48.66% |
| 2021 FY | -509.52 Million CNY | -21.37% |
| 2020 Q4 | -419.82 Million CNY | -233.67% |
| 2020 Q1 | -446.03 Million CNY | 66.21% |
| 2020 FY | -419.82 Million CNY | 68.19% |
| 2020 Q3 | -125.81 Million CNY | -27.59% |
| 2020 Q2 | -98.61 Million CNY | 77.89% |
| 2019 Q1 | -1.25 Billion CNY | 13.9% |
| 2019 FY | -1.31 Billion CNY | 8.01% |
| 2019 Q4 | -1.31 Billion CNY | -53.24% |
| 2019 Q3 | -861.34 Million CNY | 33.04% |
| 2019 Q2 | -1.28 Billion CNY | -2.49% |
| 2018 Q1 | -973.54 Million CNY | 31.04% |
| 2018 Q2 | -949.96 Million CNY | 2.42% |
| 2018 Q4 | -1.45 Billion CNY | -43.39% |
| 2018 Q3 | -1.01 Billion CNY | -7.01% |
| 2018 FY | -1.43 Billion CNY | -1.64% |
| 2017 Q3 | -855.95 Million CNY | -9.34% |
| 2017 FY | -1.41 Billion CNY | -43.14% |
| 2017 Q4 | -1.41 Billion CNY | -64.93% |
| 2017 Q2 | -782.86 Million CNY | -2.59% |
| 2017 Q1 | -763.09 Million CNY | 23.08% |
| 2016 FY | -986.31 Million CNY | 45.97% |
| 2016 Q4 | -992.05 Million CNY | 4.76% |
| 2016 Q3 | -1.04 Billion CNY | 5.28% |
| 2016 Q2 | -1.09 Billion CNY | -73.38% |
| 2016 Q1 | -634.22 Million CNY | 65.26% |
| 2015 Q3 | 119.63 Million CNY | -37.41% |
| 2015 Q2 | 191.13 Million CNY | 33.36% |
| 2015 Q1 | 143.31 Million CNY | 1491.35% |
| 2015 Q4 | -1.82 Billion CNY | -1625.93% |
| 2015 FY | -1.82 Billion CNY | -20369.9% |
| 2014 FY | 9 Million CNY | 101.79% |
| 2014 Q2 | -230.77 Million CNY | 24.32% |
| 2014 Q4 | 9 Million CNY | 106.95% |
| 2014 Q3 | -129.59 Million CNY | 43.85% |
| 2014 Q1 | -304.95 Million CNY | 39.25% |
| 2013 Q4 | -501.97 Million CNY | -8.55% |
| 2013 FY | -501.97 Million CNY | 13.83% |
| 2013 Q2 | -553.35 Million CNY | 0.47% |
| 2013 Q3 | -462.42 Million CNY | 16.43% |
| 2013 Q1 | -555.99 Million CNY | 4.56% |
| 2012 Q3 | -641.65 Million CNY | 2.72% |
| 2012 Q1 | -698.56 Million CNY | 9.2% |
| 2012 Q2 | -659.56 Million CNY | 5.58% |
| 2012 FY | -582.57 Million CNY | 24.28% |
| 2012 Q4 | -582.57 Million CNY | 9.21% |
| 2011 Q3 | -776.85 Million CNY | -62655.22% |
| 2011 Q4 | -769.34 Million CNY | 0.97% |
| 2011 Q2 | -1.23 Million CNY | 0.0% |
| 2011 FY | -769.34 Million CNY | -2682.41% |
| 2010 FY | 29.79 Million CNY | 642.56% |
| 2010 Q4 | 29.79 Million CNY | 0.0% |
| 2009 FY | 4.01 Million CNY | -57.26% |
| 2008 FY | 9.38 Million CNY | 0.0% |